Key Takeaways
- D-Wave Quantum (QBTS) shares have plummeted approximately 40% year-to-date in 2026, finishing Tuesday’s session at $16.41, down 2.50%.
- The company secured a finalized agreement with the U.S. Department of Commerce for potential CHIPS and Science Act funding up to $100M.
- Second quarter 2026 revenue totaled $3.1M, falling short of analyst expectations of $4M and declining slightly year-over-year.
- The company is set to present its dual quantum computing platform at the upcoming Quantum World Congress 2026 in Maryland from September 23-25.
- Analysts maintain a Strong Buy rating on QBTS with a consensus price target of $35.46, suggesting potential upside of approximately 116%.
D-Wave Quantum (QBTS) is experiencing significant headwinds in 2026. Shares have declined roughly 40% since the start of the year, with Tuesday’s closing price landing at $16.41, and disappointing second-quarter results have only intensified investor concerns.
The company reported Q2 2026 revenue of $3.1 million, significantly missing analyst consensus estimates of $4 million. This figure also marked a marginal year-over-year decrease of less than 1%, particularly disappointing when several competing quantum computing firms delivered triple-digit percentage revenue increases during the identical timeframe.
Management attributed the revenue miss primarily to timing complications. Several expected customer contracts either didn’t materialize or weren’t finalized within the reporting period. This situation underscores a persistent challenge: D-Wave’s revenue streams remain inconsistent and heavily dependent on a limited customer base, creating inherent volatility in quarterly performance.
Meanwhile, IonQ, a key competitor in the quantum space, delivered impressive earnings results for the same quarter, widening the performance divide between quantum companies successfully monetizing commercial opportunities and those still navigating the path to consistent revenue generation.
Shares of D-Wave have declined approximately 17% in just the past month, with the Q2 earnings disappointment serving as the primary driver of the selloff.
Major Federal Funding Agreement Provides Support
On September 14, D-Wave completed a binding agreement with the U.S. Department of Commerce, obtaining access to as much as $100 million in capital through the CHIPS and Science Act initiative.
CEO Dr. Alan Baratz characterized the funding award as evidence that federal authorities are committed to advancing quantum technology toward commercial viability rather than limiting support to theoretical research stages.
Critically, this funding is structured as non-dilutive, protecting existing shareholders from equity dilution that typically accompanies capital raises. This structure provides both financial support and third-party validation during a period of market uncertainty.
While the capital injection won’t transform D-Wave’s near-term financials overnight, it should accelerate research and development initiatives and strengthen credibility with prospective enterprise clients.
Company to Showcase Dual-Platform Approach at Industry Event
D-Wave has signed on as a platinum sponsor for the Quantum World Congress 2026, taking place September 23-25 in College Park, Maryland.
The company intends to highlight real-world commercial applications from its quantum annealing systems, which are currently deployed for optimization challenges across both private enterprises and government agencies. Additionally, D-Wave will provide updates on its gate-model quantum computing development.
Chief Science Officer Robert Schoelkopf is slated to deliver a plenary address on September 25, discussing D-Wave’s dual-platform strategy and recent advancements in hardware-level erasure detectionāa technique the company claims can significantly lower both costs and technical complexity associated with quantum error correction.
Conference attendees will have access to live demonstrations of both the annealing and gate-model quantum processing systems.
Even with the positive conference developments, QBTS shares declined an additional 0.30% as the week began.
Based on data from TipRanks, 14 Wall Street analysts have issued Strong Buy ratings on QBTS within the last three months, establishing an average price target of $35.46, which represents approximately 116% potential upside from current trading levels.





